Cargando…

VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2

The von Hippel-Lindau (VHL) is deficient in ∼70% of clear-cell renal cell carcinomas (ccRCC), which contributes to the carcinogenesis and drug resistance of ccRCC. Here we show that VHL-deficient ccRCC cells present enhanced cytotoxicity of anthracyclines in a hypoxia-inducible factor-independent ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yao-Hui, Wu, Zhao-Xia, Xie, Li-Qi, Li, Cai-Xia, Mao, Yu-Qin, Duan, Yan-Tao, Han, Bing, Han, San-Feng, Yu, Yun, Lu, Hao-Jie, Yang, Peng-Yuan, Xu, Tian-Rui, Xia, Jing-Lin, Chen, Guo-Qiang, Wang, Li-Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481740/ https://www.ncbi.nlm.nih.gov/pubmed/28643803 http://dx.doi.org/10.1038/ncomms15337

Ejemplares similares

The up‐regulation of NDRG1 by HIF counteracts the cancer‐promoting effect of HIF in VHL‐deficient clear cell renal cell carcinoma
por: Zhang, Zheng‐Yan, et al.
Publicado: (2020)

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α
por: Fan, Yang, et al.
Publicado: (2016)

Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
por: Sourbier, Carole, et al.
Publicado: (2012)

Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma
por: Xie, Jun, et al.
Publicado: (2016)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
por: Wang, Xuechun, et al.
Publicado: (2022)

Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
por: Moore, Lee E., et al.
Publicado: (2011)

Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
por: Kim, Hyeong Su, et al.
Publicado: (2018)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma
por: Nelson, Luke J, et al.
Publicado: (2022)

Cytosine 5-hydroxymethylation regulates VHL gene expression in renal clear cell carcinoma
por: Ma, En-Guang, et al.
Publicado: (2017)

VHL-deficiency leads to reductive stress in renal cells
por: Vellama, Hans, et al.
Publicado: (2023)

ALDH2 protects against stroke by clearing 4-HNE
por: Guo, Jin-Min, et al.
Publicado: (2013)

Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma
por: Yang, Wuping, et al.
Publicado: (2021)

Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2α and inhibits tumor growth
por: Chen, Lixia, et al.
Publicado: (2016)

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
por: Stewart, Grant D., et al.
Publicado: (2016)

Kidney in VHL disease: Early clear cell proliferation occurs in the distal tubular system
por: Al-Gharaibeh, Nayef S., et al.
Publicado: (2022)

Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells
por: Gao, Lei, et al.
Publicado: (2013)

Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma
por: Noonan, Haley R., et al.
Publicado: (2016)

VHL Dependent Expression of REDD1 and PDK3 Proteins in Clear-cell Renal Cell Carcinoma
por: Ilic, Bojana B, et al.
Publicado: (2018)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
por: Ganner, Athina, et al.
Publicado: (2021)

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012)

Retraction: Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells
por: Gao, Lei, et al.
Publicado: (2014)

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
por: Shen, H.-C. Jennifer, et al.
Publicado: (2009)

Combined Vhl, Trp53 and Rb1 mutation causes clear cell renal cell carcinoma in mice
por: Harlander, Sabine, et al.
Publicado: (2017)

Bexarotene – a novel modulator of AURKA and the primary cilium in VHL-deficient cells
por: Chowdhury, Pratim, et al.
Publicado: (2018)

Rho-Associated Kinase 1 (ROCK1) inhibition is Synthetically Lethal with Von Hippel Lindau (VHL) Deficiency in Clear Cell Renal Cell Carcinoma (CC-RCC)
por: Thompson, Jordan M., et al.
Publicado: (2016)

Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Martin, Benedicte, et al.
Publicado: (2013)

MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma
por: Bailey, Sean T., et al.
Publicado: (2017)

PBX1, EMCN and ERG are associated with the sub-clusters and the prognosis of VHL mutant clear cell renal cell carcinoma
por: Wang, Haiwei, et al.
Publicado: (2022)

The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
por: Cinque, Alessandra, et al.
Publicado: (2022)

VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009)

Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma
por: Guo, Kai, et al.
Publicado: (2022)

Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
por: Moore, L E, et al.
Publicado: (2012)

VHL syndrome without clear family history: A rare case report and literature review of Chinese patients
por: Li, Yaheng, et al.
Publicado: (2022)

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma
por: Gossage, Lucy, et al.
Publicado: (2014)

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
por: Mazumder, Sonia, et al.
Publicado: (2023)

Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma
por: Huang, Wan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rdg2fo68fo47gvtvid9e1tsq0c